Pfizer Allows Others To Make Its Covid Pill, 53% Of The World To Benefit
With this, Pfizer’s oral antiviral Covid-19 medication will be available more cheaply in poorer countries, if it passes trials and regulatory approval. US pharmaceutical giant Pfizer on Tuesday announced a deal to make its prospective antiviral Covid-19 pill available more cheaply in the world’s least wealthy countries. Pfizer will sub-licence production of its promising Paxlovid pill to generic drug manufacturers for supply in 95 low- and middle-income nations covering around 53 percent of the world’s population. Under the deal struck with the global Medicines Patent Pool (MPP), Pfizer — which…
Read More